News
Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...
Researchers who discovered a mechanism that prevents B cells from attacking the body’s own tissues in autoimmune diseases win ...
Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...
The appointment of Dr. Banerjee culminates Artiva's efforts to build a seasoned development team with strong expertise in ...
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies ...
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...
The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...
Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...
Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...
13d
News-Medical.Net on MSNFusion proteins enable the creation of monoclonal antibodiesThe Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...
While cisgender females do have better protection against infectious diseases such as COVID-19 and hepatitis B, this is balanced out by being more susceptible to autoimmune conditions such as lupus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results